Ferroptosis in arterial atherosclerosis: mechanistic hypotheses, cell type specific vulnerabilities, translational biomarkers, and therapeutic opportunities - Takeaways - MDSpire

Ferroptosis in arterial atherosclerosis: mechanistic hypotheses, cell type specific vulnerabilities, translational biomarkers, and therapeutic opportunities

  • By

  • Cai Li

  • Jinxia Wang

  • Jingyi Sun

  • June 24, 2026

  • 0 min

Share

  • 1

    Atherosclerosis is a leading cause of myocardial infarctions and ischemic strokes, with residual risk linked to vascular inflammation and oxidative stress.

  • 2

    Ferroptosis, an iron-dependent cell death, may contribute to endothelial dysfunction and necrotic core expansion in atherosclerotic plaques.

  • 3

    Current understanding of ferroptosis in atherosclerosis is limited by inconsistent definitions and reliance on non-specific oxidative stress markers.

  • 4

    Cell-type-specific vulnerabilities to ferroptosis are influenced by factors such as disturbed flow, dyslipidemia, and innate immune signaling.

  • 5

    Identifying ferroptosis-specific signatures in human tissues is essential for developing clinically actionable risk assessment strategies.

Original Source(s)

Ferroptosis in arterial atherosclerosis: mechanistic hypotheses, cell type specific vulnerabilities, translational biomarkers, and therapeutic opportunities

  • by Cai Li, Jinxia Wang, Jingyi Sun

  • June 24, 2026

Related Content

FDA Approves Baxdrostat for Resistant Hypertension

Phase 3 findings support the oral therapy in adults with persistent blood pressure elevation despite multidrug treatment.

Associations of clinical obesity with arterial stiffness and cerebral small vessel disease: a population-based study

Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank